Supported Research
Development of Virotherapy Using Retargeted Adenoviruses to Eradicate Preneopolastic Lesions for the Oral Cavity and Oropharynx
Amount Funded: $116,000
Researchers: Ruud Brakenhoff , Hans Joenje , Vincent van Beusechem
Amount Funded: $116,000
Researchers: Ruud Brakenhoff , Hans Joenje , Vincent van Beusechem